New Study In Nature Medicine Shows Novel Neuroprotective Drug Candidate Meets Primary Endpoint In Patients With Mild To ...
(MENAFN- PR Newswire) Study exemplifies how ADDF funding fuels progress of innovative science guided by the biology of aging for future of Alzheimer's treatment. NEW YORK, May 17, 2024 /PRNewswire/ -- A study published today in Nature Medicine …